FibroBiologics, Inc.
Pharmaceuticals · HOUSTON, TX
PharmaceuticalsSEC Form D
FibroBiologics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 29, 2026, reporting $3,000,000 raised.
Incorporated in Delaware and based in HOUSTON, TX, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that FibroBiologics, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Pete O'HeeronExecutive Officer · Director
- Robert HoffmanDirector
- Matthew LinkDirector
- Victoria NiklasDirector
- Richard C. CilentoDirector
- Jason D. DavisExecutive Officer
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$1.9MRaised
Liminatus Pharma, Inc.
$384.8KRaised
Spine BioPharma, Inc.
$50.0KRaised